SpectraCure AB (publ)

Stockholm Stock Exchange SPEC.ST

SpectraCure AB (publ) Market Capitalization on January 14, 2025: USD 25.96 M

SpectraCure AB (publ) Market Capitalization is USD 25.96 M on January 14, 2025, a -20.47% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

SpectraCure AB (publ) 52-week high Market Capitalization is USD 44.57 M on December 16, 2024, which is 71.65% above the current Market Capitalization.
SpectraCure AB (publ) 52-week low Market Capitalization is USD 9.97 M on December 09, 2024, which is -61.60% below the current Market Capitalization.
SpectraCure AB (publ) average Market Capitalization for the last 52 weeks is USD 21.10 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Stockholm Stock Exchange: SPEC.ST

SpectraCure AB (publ)

CEO	Dr. Masoud Khayyami Ph.D.
IPO Date	July 1, 2015
Location	Sweden
Headquarters	Gasverksgatan 1
Employees	13
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.

Key trends

Past 5 years